<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4376671</article-id><article-id pub-id-type="pmid">25816354</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0122242</article-id><article-id pub-id-type="publisher-id">PONE-D-14-27320</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Small-Quantity Lipid-Based Nutrient Supplements, Regardless of Their Zinc Content, Increase Growth and Reduce the Prevalence of Stunting and Wasting in Young Burkinabe Children: A Cluster-Randomized Trial </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">SQ-LNS along with Illness Treatment Reduces Stunting in Young Children</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hess</surname><given-names>Sonja Y.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Abbeddou</surname><given-names>Souheila</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jimenez</surname><given-names>Elizabeth Yakes</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Somé</surname><given-names>Jérôme W.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vosti</surname><given-names>Stephen A.</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ouédraogo</surname><given-names>Zinéwendé P.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guissou</surname><given-names>Rosemonde M.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ouédraogo</surname><given-names>Jean-Bosco</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Kenneth H.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Program in International and Community Nutrition, Department of Nutrition, University of California Davis, Davis, CA, United States of America</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Nutrition Program, Department of Individual, Family and Community Education, University of New Mexico, Albuquerque, NM, United States of America</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>Agricultural and Resource Economics, University of California Davis, Davis, CA, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Beeson</surname><given-names>James G.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Burnet Institute, AUSTRALIA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><text><SENT sid="1" pm="."><plain>Competing Interests: KHB has worked as a consultant and later as employee for the Bill &amp; Melinda Gates Foundation. </plain></SENT>
<SENT sid="2" pm="."><plain>SA declares non-financial support from Nutriset SAS, outside the submitted work. </plain></SENT>
<SENT sid="3" pm="."><plain>None of the other authors have a conflict of interest to declare. </plain></SENT>
<SENT sid="4" pm="."><plain>This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. </plain></SENT>
</text></p></fn><fn fn-type="con" id="contrib001"><p><text><SENT sid="5" pm="."><plain>Conceived and designed the experiments: KHB SYH JBO. </plain></SENT>
<SENT sid="6" pm="."><plain>Performed the experiments: SA EYJ JWS ZPO RMG SYH KHB SAV JBO. </plain></SENT>
<SENT sid="7" pm="."><plain>Analyzed the data: SA JWS. </plain></SENT>
<SENT sid="8" pm="."><plain>Wrote the paper: KHB SA EYJ. </plain></SENT>
</text></p></fn><corresp id="cor001">* E-mail: <email>syhess@ucdavis.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>e0122242</elocation-id><history><date date-type="received"><day>20</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>12</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>© 2015 Hess et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Hess et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0122242.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="9" pm="."><plain>Small-quantity lipid-based nutrient supplements (SQ-LNS) are promising home fortification products, but the optimal zinc level needed to improve growth and reduce morbidity is uncertain. </plain></SENT>
<SENT sid="10" pm="."><plain>We aimed to assess the impact of providing SQ-LNS with varied amounts of zinc, along with illness treatment, on zinc-related outcomes compared with standard care. </plain></SENT>
<SENT sid="11" pm="."><plain>In a placebo-controlled, cluster-randomized trial, 34 communities were stratified to intervention (IC) or non-intervention cohorts (NIC). </plain></SENT>
<SENT sid="12" pm="."><plain>2435 eligible IC children were randomly assigned to one of four groups:1) SQ-LNS without zinc, placebo tablet; 2) SQ-LNS containing 5mg zinc, placebo tablet; 3) SQ-LNS containing 10mg zinc, placebo tablet; or 4) SQ-LNS without zinc and 5mg zinc tablet from 9–18 months of age. </plain></SENT>
<SENT sid="13" pm="."><plain>During weekly morbidity surveillance, oral rehydration salts were provided for reported diarrhea and antimalarial therapy for confirmed malaria. </plain></SENT>
<SENT sid="14" pm="."><plain>Children in NIC (n = 785) did not receive SQ-LNS, tablets, illness surveillance or treatment. </plain></SENT>
<SENT sid="15" pm="."><plain>At 9 and 18 months, length, weight and hemoglobin were measured in all children. </plain></SENT>
<SENT sid="16" pm="."><plain>Reported adherence was 97±6% for SQ-LNS and tablets. </plain></SENT>
<SENT sid="17" pm="."><plain>Mean baseline hemoglobin was 89±15g/L. </plain></SENT>
<SENT sid="18" pm="."><plain>At 18 months, change in hemoglobin was greater in IC than NIC (+8 vs -1g/L, p&lt;0.0001), but 79.1% of IC were still anemic (vs. 91.1% in NIC). </plain></SENT>
<SENT sid="19" pm="."><plain>Final plasma zinc concentration did not differ by group. </plain></SENT>
<SENT sid="20" pm="."><plain>During the 9-month observation period, the incidence of diarrhea was 1.10±1.03 and of malaria 0.54±0.50 episodes per 100 child-days, and did not differ by group. </plain></SENT>
<SENT sid="21" pm="."><plain>Length at 18 months was significantly greater in IC compared to NIC (77.7±3.0 vs. 76.9±3.4cm; p&lt;0.001) and stunting prevalence was significantly lower in IC (29.3%) than NIC (39.3%; p&lt;0.0001), but did not differ by intervention group within IC. </plain></SENT>
<SENT sid="22" pm="."><plain>Wasting prevalence was also significantly lower in IC (8.7%) than in NIC (13.5%; p = 0.0003). </plain></SENT>
<SENT sid="23" pm="."><plain>Providing SQ-LNS daily with or without zinc, along with malaria and diarrhea treatment, significantly increased growth and reduced stunting, wasting and anemia prevalence in young children. </plain></SENT>
</text></SecTag></p><sec id="sec001"><title><text><SENT sid="24" pm="."><plain>Trial Registration </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="25" pm="."><plain>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00944281">NCT00944281</ext-link> </plain></SENT>
</text></SecTag></p></sec></abstract><funding-group><funding-statement>The project was funded by a grant from the Bill &amp; Melinda Gates Foundation to the University of California, Davis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="19"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All files are available from the Figshare database (accession number <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.6084/m9.figshare.1301239">http://dx.doi.org/10.6084/m9.figshare.1301239</ext-link>).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All files are available from the Figshare database (accession number <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.6084/m9.figshare.1301239">http://dx.doi.org/10.6084/m9.figshare.1301239</ext-link>).</p></notes></front><body><SecTag type="INTRO"><sec sec-type="intro" id="sec002"><title><text><SENT sid="26" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="27" pm="."><plain>Growth stunting in early life continues to be a critical public health concern in low-income countries [1,2]. </plain></SENT>
<SENT sid="28" pm="."><plain>Diarrhea and pneumonia are leading causes of morbidity and mortality among young children in low income countries and the case fatality for these illnesses is increased in undernourished children [3,4]. </plain></SENT>
<SENT sid="29" pm="."><plain>Although the global malaria burden has decreased in the past decade, it remains very high in sub-Saharan Africa [5]. </plain></SENT>
<SENT sid="30" pm="."><plain>Supplemental zinc increases linear growth and weight gain and reduces the incidence of diarrhea and pneumonia among children under 5 years of age [6–10]. </plain></SENT>
<SENT sid="31" pm="."><plain>Small quantity lipid-based nutrient supplements (SQ-LNS) have been designed to prevent undernutrition and promote health and development [11]. </plain></SENT>
<SENT sid="32" pm="."><plain>SQ-LNS provide ~20 g or ~110–120 kcal per day along with additional protein, essential fatty acids and 22 micronutrients, including zinc. </plain></SENT>
<SENT sid="33" pm="."><plain>Trials investigating the potential of SQ-LNS and medium-quantity LNS (MQ-LNS; at ~50 g or ~250–280 kcal per day) to prevent malnutrition and promote growth have yielded mixed results [12–17]. </plain></SENT>
<SENT sid="34" pm="."><plain>Only a few of these studies reported morbidity outcomes, and none detected any benefit of SQ-LNS [14,15]. </plain></SENT>
<SENT sid="35" pm="."><plain>Thus, the beneficial impact of zinc on growth and morbidity is less clear when provided mixed with food, such as point-of-use fortification of complementary foods with SQ-LNS or multiple micronutrient powders (MNP), possibly because of insufficient zinc content. </plain></SENT>
</text></p><p><text><SENT sid="36" pm="."><plain>While there is strong evidence that providing 3–20 mg zinc supplements daily as syrup or tablets consistently results in significantly increased plasma zinc concentrations (pZn) in the zinc supplemented group compared to the placebo control group [18], findings from home fortification trials are inconsistent. </plain></SENT>
<SENT sid="37" pm="."><plain>Most, but not all, studies providing 5 mg zinc in a daily dose of SQ-LNS or MNP did not find increased pZn at the end of the study [19–21]. </plain></SENT>
<SENT sid="38" pm="."><plain>One study in young Iranian children who received 5 mg of zinc in MNP and one study in young Cambodian children who received 10 mg of zinc in MNP found a significantly increased pZn at the end of the study compared to a placebo control group and non-intervention group, respectively [22,23]. </plain></SENT>
<SENT sid="39" pm="."><plain>Possible explanations for this lack of response in biochemical and functional outcomes are: 1) the dose of zinc was inadequate because less zinc is absorbed from zinc-containing preparations that are provided with meals than from water-soluble zinc supplements provided between meals, 2) the study populations were not zinc deficient, so they did not respond functionally to additional zinc, and/or 3) zinc consumed with meals was taken up preferentially by non-metabolically active zinc pools. </plain></SENT>
</text></p><p><text><SENT sid="40" pm="."><plain>The present study had two primary objectives: 1) To compare zinc-related functional responses among young Burkinabe children who received SQ-LNS containing 0, 5 or 10 mg of zinc and placebo tablet or SQ-LNS without added zinc, plus 5 mg zinc tablets along with treatment for diarrhea and malaria episodes; and 2) to compare the impact of the intervention package among children in intervention vs. non-intervention communities. </plain></SENT>
<SENT sid="41" pm="."><plain>Cluster-randomization at the level of the family compound (i.e. concession) in the intervention communities was used to prevent cross-contamination between intervention groups through food sharing. </plain></SENT>
<SENT sid="42" pm="."><plain>Major outcomes included physical growth, morbidity from common infections (specifically, diarrhea and malaria), and change in pZn. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="sec003"><title><text><SENT sid="43" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>The protocol for this trial and supporting CONSORT checklist are available as supporting information; see S1 CONSORT Checklist and S1 Protocol. </plain></SENT>
</text></p><sec id="sec004"><title><text><SENT sid="45" pm="."><plain>Study Design and Participants </plain></SENT>
</text></title><p><text><SENT sid="46" pm="."><plain>The study was designed as a partially masked, placebo-controlled, cluster-randomized intervention trial. </plain></SENT>
<SENT sid="47" pm="."><plain>The trial was conducted from April 2010 to July 2012 in rural communities of the Dandé Health District in southwestern Burkina Faso. </plain></SENT>
<SENT sid="48" pm="."><plain>Ethical approval for the study protocol and the consent procedure was provided by the Institutional Review Boards of the Centre Muraz in Bobo-Dioulasso (Burkina Faso) and the University of California Davis (USA). </plain></SENT>
<SENT sid="49" pm="."><plain>The study was registered as a clinical trial with the U.S. </plain></SENT>
<SENT sid="50" pm="."><plain>National Institutes of Health (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00944281">NCT00944281</ext-link>;). </plain></SENT>
</text></p><p><text><SENT sid="51" pm="."><plain>Nine-month old infants were identified by periodic censuses in the study area. </plain></SENT>
<SENT sid="52" pm="."><plain>Written, informed consent was obtained from one of the child’s primary caregivers (mother, father or legal guardian). </plain></SENT>
<SENT sid="53" pm="."><plain>In case the caregiver was illiterate, an impartial witness was present during the consent process, who confirmed that the information in the consent document was accurately explained to the participant, and that consent was freely given. </plain></SENT>
<SENT sid="54" pm="."><plain>Children were considered eligible if they were 8.8 to 9.9 months of age, resided permanently in the area, planned to be available during the study period and had written parental consent. </plain></SENT>
<SENT sid="55" pm="."><plain>Exclusion criteria were: hemoglobin (Hb) &lt;50 g/L, weight-for-length &lt;70% of the median of the National Center for Health Statistics/World Health Organization (NCHS/WHO) growth reference [24] presence of bipedal edema, other severe illness warranting hospital referral, congenital abnormalities potentially interfering with growth, chronic medical conditions requiring frequent medical attention, known HIV infection of infant or mother, history of allergy towards peanuts, history of anaphylaxis or serious allergic reaction to any substance requiring emergency medical care, and concurrent participation in any other clinical trial. </plain></SENT>
<SENT sid="56" pm="."><plain>Once enrolled, children were withdrawn from study participation when absent from the study for more than 3 weeks, although data collected until that time were retained. </plain></SENT>
</text></p></sec><sec id="sec005"><title><text><SENT sid="57" pm="."><plain>Sample Size </plain></SENT>
</text></title><p><text><SENT sid="58" pm="."><plain>The sample size estimates were based on the number of children needed in each group to detect (with a significance level of P&lt;0.05 and power &gt;0.80) effect sizes that are consistent with the magnitude of effects observed in previous zinc supplementation trials [6,25]. </plain></SENT>
<SENT sid="59" pm="."><plain>In particular, the sample sizes were based on an effect size of &gt;0.22 for diarrhea incidence, malaria incidence, and physical growth; and 0.6 for change in pZn. </plain></SENT>
<SENT sid="60" pm="."><plain>The target sample size per intervention group for incidence of diarrhea and malaria and growth was n = 583 and for biochemical indicators of nutritional status n = 85. </plain></SENT>
<SENT sid="61" pm="."><plain>This included an assumed attrition rate of 15% for morbidity and growth outcomes and 20% for the biochemical outcomes. </plain></SENT>
<SENT sid="62" pm="."><plain>The estimated sample size for the NIC was increased for an assumed design effect of 1.5 due to the cluster sampling design. </plain></SENT>
</text></p></sec><sec id="sec006"><title><text><SENT sid="63" pm="."><plain>Randomization and Masking </plain></SENT>
</text></title><p><text><SENT sid="64" pm="."><plain>This trial included two levels of randomization: 1) the community and 2) the concession. </plain></SENT>
<SENT sid="65" pm="."><plain>Thirty-four communities that were accessible year-round were chosen. </plain></SENT>
<SENT sid="66" pm="."><plain>A statistician at the University of California Davis stratified individual communities by selected indicators (population size; proximity to road and Bobo-Dioulasso; and health clinic affiliation) and computer-generated an assignment within strata to participate in the intervention cohort (IC; 25 communities) or in the non-intervention cohort (NIC; 9 communities). </plain></SENT>
<SENT sid="67" pm="."><plain>The same statistician, who was blinded to the intervention, generated a random allocation sequence at the level of the concession for the enrollment of eligible infants in the IC. </plain></SENT>
<SENT sid="68" pm="."><plain>Eligible children meeting the inclusion criteria were allocated to one of four interventions from 9 to 18 months of age: 1) SQ-LNS without zinc, and placebo tablet (LNS-Zn0), 2) SQ-LNS with 5 mg zinc, and placebo tablet (LNS-Zn5), 3) SQ-LNS with 10 mg zinc, and placebo tablet (LNS-Zn10), or 4) SQ-LNS without zinc, and 5 mg zinc tablet (LNS-TabZn5). </plain></SENT>
<SENT sid="69" pm="."><plain>Children in the intervention groups received free treatment for diarrhea, malaria and fever, as described in more detail below. </plain></SENT>
<SENT sid="70" pm="."><plain>Children in the NIC did not receive SQ-LNS or tablets from 9 to 18 months of age, nor any illness treatment, but received SQ-LNS from 18 to 27 months after the data collection was finished. </plain></SENT>
<SENT sid="71" pm="."><plain>The trial was partially masked, as all participants, field staff and researchers remained blinded to the four intervention groups until data analyses were completed, but were aware which communities were assigned to IC and NIC. </plain></SENT>
</text></p><p><text><SENT sid="72" pm="."><plain>The LNS products were developed for the iLiNS project [11] by Nutriset SAS (Malaunay, France) and tested for acceptability [26]. </plain></SENT>
<SENT sid="73" pm="."><plain>A weekly ration of LNS was initially delivered to participating children in plastic cups containing 140 g (sufficient for one week) and later in seven sachets containing 20 g each. </plain></SENT>
<SENT sid="74" pm="."><plain>The child’s caregiver was advised to feed the day’s allotment (20 g = 2 spoonsful) mixed in food during two separate meal times. </plain></SENT>
<SENT sid="75" pm="."><plain>The LNS for each treatment group were identical, except for their zinc content. </plain></SENT>
<SENT sid="76" pm="."><plain>Besides zinc, a daily ration of LNS provided 118 kcal and 6 mg iron along with 20 other micronutrients [11]. Table 1 shows the nutrient content of a daily ration of SQ-LNS compared with the Recommended Nutrient Intakes by WHO and the Food and Agriculture Organization of the United Nations (FAO) [27,28]. </plain></SENT>
<SENT sid="77" pm="."><plain>Zinc tablets were provided as water-dispersible tablets produced by Nutriset SAS (Malaunay, France) containing 5 mg zinc or an identical placebo. </plain></SENT>
<SENT sid="78" pm="."><plain>The caregivers were advised to provide the tablet once daily, dissolved in water or breast milk, but not with other foods. </plain></SENT>
<SENT sid="79" pm="."><plain>SQ-LNS and packages of tablets were labeled with one of eight color codes (two colors per intervention group). </plain></SENT>
<SENT sid="80" pm="."><plain>Caregivers were given brief feeding advice at enrollment, which included the above-described instructions for SQ-LNS and tablets and recommendations to continue breastfeeding and to provide a variety of nutritious foods. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0122242.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="81" pm="."><plain>Nutrients provided in 20 g SQ-LNS for infants and young children, in comparison to World Health Organization/Food and Agriculture Organization (WHO/FAO) Recommended Nutrient Intakes (RNI) [27]. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0122242.t001g" xlink:href="pone.0122242.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>Nutrient </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Unit </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>SQ-LNS </plain></SENT>
</text></th><th colspan="2" align="center" rowspan="1"><text><SENT sid="85" pm="."><plain>WHO/FAO RNI </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>7–12 months </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>1–3 yrs </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>Energy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>kcal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>118 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>Protein </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>g </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>10.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>11.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>Fat </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>g </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>9.6 </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="101" pm="."><plain>40–60% energy 1  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>    Linoleic acid </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>4.46 </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="105" pm="."><plain>3.0–4.5% energy </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>    α-Linolenic acid </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>G </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>0.58 </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="109" pm="."><plain>0.4–0.6% energy </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>Vitamin A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>400 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>Thiamin (B1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>0.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>Riboflavin (B2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>0.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>Niacin (B3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>Pantothenic acid (B5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>1.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>1.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>Vitamin B6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>0.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>0.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>Vitamin B12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>0.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>0.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>0.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Folic acid </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>80 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>80 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>150 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>Vitamin C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>30 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>Vitamin D </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>Vitamin E </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>2.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>Vitamin K </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>15 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>Calcium </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>280 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>500 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>Copper </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>0.34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>Iodine </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>Μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>90 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>Iron </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>18.6 2  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>11.6 2  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>Magnesium </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>40 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>60 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>Manganese </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>1.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>Phosphorus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>190 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>Potassium </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>200 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>Selenium </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>μg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>17 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>Zinc </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>mg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>0, 5 or 10 3  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>8.4 4  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>8.3 4  </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><text><SENT sid="220" pm="."><plain>1 Acceptable macronutrient distribution range recommended to reduce gradually from 40–60% at 6 months to 35% at 24 months and to 25–35% for 2 years and older [28]. </plain></SENT>
</text></p></fn><fn id="t001fn002"><p><text><SENT sid="221" pm="."><plain>2 RNI for an assumed bioavailability of 5%. </plain></SENT>
</text></p></fn><fn id="t001fn003"><p><text><SENT sid="222" pm="."><plain>3 Zinc content depending on intervention group. </plain></SENT>
</text></p></fn><fn id="t001fn004"><p><text><SENT sid="223" pm="."><plain>4 RNI for low bioavailability. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="sec007"><title><text><SENT sid="224" pm="."><plain>Procedures </plain></SENT>
</text></title><p><text><SENT sid="225" pm="."><plain>At the time of enrollment, children’s length, weight, mid-upper arm circumference (MUAC) and head circumference (HC) were measured in IC and NIC. </plain></SENT>
<SENT sid="226" pm="."><plain>Maternal height and weight, and information on the child’s dietary practices and family socio-economic status (SES) were also obtained for all children. </plain></SENT>
<SENT sid="227" pm="."><plain>The age of the participants was confirmed from health cards. </plain></SENT>
<SENT sid="228" pm="."><plain>A capillary sample was collected for onsite analyses of Hb concentration (Hemocue 201+, HemoCue AB, Ängelholm, Sweden) and a rapid diagnostic test (RDT) for malaria parasites, based on histidine-rich protein II (SD BIOLINE Malaria Ag P.F/Pan, Standard Diagnostics, INC., Kyonggi-do, Korea). </plain></SENT>
<SENT sid="229" pm="."><plain>Capillary blood (300 μL) was collected in microcuvettes containing lithium heparin (CB 300 LH, Sarstedt AG &amp; Co, Nümbrecht, Germany) for assessment of zinc protoporphyrin (ZPP) concentration. </plain></SENT>
<SENT sid="230" pm="."><plain>In case of illness, all children screened received free medical treatment(s): in case of diarrhea oral rehydration salts (ORS) packets were provided, children with fever received paracetamol and children with a positive RDT received anti-malarial treatment (artesunate-amodiaquine combination therapy and paracetamol). </plain></SENT>
<SENT sid="231" pm="."><plain>Children with Hb &lt;80 g/L received anthelmintic treatment (mebendazole 200 mg/day for 3 days) and iron supplements (2–6 mg iron/kg body weight for 30 days). </plain></SENT>
<SENT sid="232" pm="."><plain>Children with weight-for-length &lt;70% of the median of the NCHS/WHO growth reference [24] or with malaria or diarrhea with complications or any other illness requiring medical follow up were referred to the health center. </plain></SENT>
<SENT sid="233" pm="."><plain>Enrollment continued until the target sample size was met. </plain></SENT>
<SENT sid="234" pm="."><plain>In the case of twins, both were enrolled in the study, but only one was randomly selected for inclusion in the data analysis. </plain></SENT>
</text></p><p><text><SENT sid="235" pm="."><plain>Children in the IC were visited weekly for delivery of intervention products and morbidity surveillance using standardized data collection tools. </plain></SENT>
<SENT sid="236" pm="."><plain>During each visit, reported LNS and tablet consumption was recorded, and empty and unused packages were collected for assessment of adherence. </plain></SENT>
<SENT sid="237" pm="."><plain>At each visit, the field worker evaluated the child for the presence of clinical danger signs, and evidence of uncomplicated diarrhea, fever, or malaria, which were treated in the community, as described above. </plain></SENT>
<SENT sid="238" pm="."><plain>In case of reported fever on the day of or the day before the surveillance visit, the field worker performed an RDT and measured aural body temperature. </plain></SENT>
<SENT sid="239" pm="."><plain>Children with danger signs, and diarrhea, fever and malaria with complications and any other cases of severe illness were referred to the health center for evaluation and treatment. </plain></SENT>
<SENT sid="240" pm="."><plain>Surveillance field workers participated in regular training, and refresher sessions and were overseen by field supervisors and two study physicians. </plain></SENT>
<SENT sid="241" pm="."><plain>A randomly selected sub-sample of children participated in 12-hr home observations at 11 and 16 months of age, as described in more detail elsewhere [29]. </plain></SENT>
</text></p><p><text><SENT sid="242" pm="."><plain>The anthropometric measurements described above were repeated at 12 and 15 months in IC only. </plain></SENT>
<SENT sid="243" pm="."><plain>From the age of 9 to 18 months, children in NIC were not supplemented nor visited by study personnel; they relied on standard care provided by the family and health system. </plain></SENT>
<SENT sid="244" pm="."><plain>At 18 months, all children (IC and NIC) were invited for a final follow up examination, where anthropometric assessments were repeated, and Hb concentration was assessed. </plain></SENT>
<SENT sid="245" pm="."><plain>Children’s and mothers’ weights were measured to 50 g precision (Seca Model 383 and Seca Model 874) and children’s length (Seca Model 417), MUAC (26 cm Tri-Colored Single-Slotted Insertion Tape), HC (ShorrTape Measuring Tape), and mothers’ height (Seca Model 217) were measured to 0.1 cm precision. </plain></SENT>
<SENT sid="246" pm="."><plain>Four teams of two anthropometrists each completed measurements in both IC and NIC and were systematically restandardized. </plain></SENT>
<SENT sid="247" pm="."><plain>During 12 standardization sessions, the mean technical error of measurement (TEM) for length was 0.50 cm and ranged from 0.09 to 0.74 cm (N = 120) considering both intra- and inter-observer variability [30]. </plain></SENT>
</text></p><p><text><SENT sid="248" pm="."><plain>At enrollment, a subset of children in IC and NIC were randomly assigned to the “biochemistry sub-group” for a venous blood draw. </plain></SENT>
<SENT sid="249" pm="."><plain>To avoid intra-concession correlation in this sub-group, only one child was randomly selected per family compound. </plain></SENT>
<SENT sid="250" pm="."><plain>Final venous blood samples were obtained from the same sub-set of children at 18 months of age. </plain></SENT>
<SENT sid="251" pm="."><plain>On both occasions, children were free of symptoms of diarrhea and fever during the previous 48 hr, and 5 mL of blood was drawn 1–2 hr after the last breastfeeding episode from an antecubital or dorsal metacarpal vein. </plain></SENT>
<SENT sid="252" pm="."><plain>Blood was collected in evacuated, trace element-free polyethylene tubes containing lithium heparin (Sarstedt AG &amp; Co, Nümbrecht, Germany), stored on ice and transported to the field laboratory, where ZPP was assessed in unwashed capillary whole blood by hematofluorometer (206D, AVIV Biomedical Inc., Lakewood, NJ, USA). </plain></SENT>
<SENT sid="253" pm="."><plain>Plasma was separated from heparinized venous blood by centrifuging at 2800 rpm for 10 min and stored at -20°C until shipped on dry ice to the respective laboratories for analysis. </plain></SENT>
<SENT sid="254" pm="."><plain>All blood collection and processing procedures conformed with recommendations by the International Zinc Nutrition Consultative Group (IZiNCG) [31]. </plain></SENT>
<SENT sid="255" pm="."><plain>pZn was determined by inductively-coupled plasma atomic emission spectrometry following overnight digestion in 70% nitric acid at the Children’s Hospital Oakland Research Institute [32,33]. </plain></SENT>
<SENT sid="256" pm="."><plain>C-reactive protein (CRP) and α-1-acid glycoprotein (AGP) were analyzed by ELISA by DBS-Tech in Willstaett, Germany [34]. </plain></SENT>
</text></p></sec><sec id="sec008"><title><text><SENT sid="257" pm="."><plain>Outcomes </plain></SENT>
</text></title><p><text><SENT sid="258" pm="."><plain>Length-for age (LAZ), weight-for-age (WAZ), and weight-for-length z-scores (WLZ) were calculated according to the World Health Organization 2006 growth standards [35]. </plain></SENT>
<SENT sid="259" pm="."><plain>Stunting, underweight and wasting were defined as &lt;-2 standard deviation (SD) LAZ, WAZ and WLZ, respectively. </plain></SENT>
<SENT sid="260" pm="."><plain>Diarrhea was defined as the presence of ≥3 loose or liquid stools per 24 hr. </plain></SENT>
<SENT sid="261" pm="."><plain>Reported fever was defined as any fever reported by the caregiver. Confirmed fever was defined as aural temperature &gt;37.5°C. </plain></SENT>
<SENT sid="263" pm="."><plain>Any episode of reported or confirmed fever associated with a positive RDT was defined as malaria. </plain></SENT>
<SENT sid="264" pm="."><plain>A child was considered at risk for malaria if the child did not receive any antimalarial treatment within the previous 21 days. </plain></SENT>
<SENT sid="265" pm="."><plain>New episodes of diarrhea and fever were considered when at least 48 hr had elapsed since a previous episode. </plain></SENT>
<SENT sid="266" pm="."><plain>To assess food security, the Household Food Insecurity Access Scale (HFIAS [36]) was adjusted for season and year. </plain></SENT>
<SENT sid="267" pm="."><plain>Using principal components analysis, an asset index was computed from information on baseline ownership of a set of assets, lighting source, drinking water supply, sanitation facilities, and flooring materials [37]. </plain></SENT>
<SENT sid="268" pm="."><plain>pZn and ZPP concentrations were adjusted for the presence of inflammation (elevated acute phase proteins categorically defined as CRP &gt;5 mg/L, AGP &gt;1 g/L, or both). </plain></SENT>
<SENT sid="269" pm="."><plain>Cut-offs used to define deficiency for each indicator were: pZn &lt; 65 μg/dL; Hb &lt; 110 g/L; ZPP &gt;70 μmol/mol heme. </plain></SENT>
</text></p></sec><sec id="sec009"><title><text><SENT sid="270" pm="."><plain>Statistical Analyses </plain></SENT>
</text></title><p><text><SENT sid="271" pm="."><plain>The primary outcomes were growth, incidence of diarrhea, incidence of malaria and pZn. </plain></SENT>
<SENT sid="272" pm="."><plain>All statistical analyses were completed with SAS System software for Windows release 9.2 (SAS Institute, Cary, North Carolina, USA). </plain></SENT>
<SENT sid="273" pm="."><plain>Data are presented as means ± SD, unless otherwise noted. </plain></SENT>
<SENT sid="274" pm="."><plain>Treatment groups remained masked until all statistical analyses were completed and main conclusions were drawn. </plain></SENT>
</text></p><p><text><SENT sid="275" pm="."><plain>Descriptive statistics were used to examine all variables. </plain></SENT>
<SENT sid="276" pm="."><plain>Because the method of allocating communities to the two cohorts did not result in equal probabilities of being selected for intervention, selected variables were compared between cohorts using linear mixed models for continuous variables, mixed logistic regression models for binary variables, including random effects of village and concession, and Chi-square tests accounting for community for non-binary categorical variables. </plain></SENT>
<SENT sid="277" pm="."><plain>Covariates and potential effect modifiers were defined prior to analyses. </plain></SENT>
<SENT sid="278" pm="."><plain>Linear mixed model ANCOVA (SAS MIXED procedure) was used to compare anthropometric outcomes, and Hb, pZn, AGP and CRP concentrations between the two cohorts, among the four intervention groups and among the five groups (four intervention groups and NIC) with adjustment for baseline value, age, other relevant variables and random effects (village, concession, if appropriate). </plain></SENT>
<SENT sid="279" pm="."><plain>Differences in the prevalence of stunting, underweight, and wasting at the end of the study were compared with mixed model logistic regression (SAS GLIMMIX procedure) adjusting for respective baseline z-score and other co-variates. </plain></SENT>
<SENT sid="280" pm="."><plain>Potential modifying effects with an interaction with the treatment group and/or cohort were considered significant if P&lt;0.1. </plain></SENT>
<SENT sid="281" pm="."><plain>The modifying effects of baseline LAZ on the change in LAZ was examined by estimating adjusted means at the 10th, 50th and 90th percentile of baseline LAZ. </plain></SENT>
</text></p><p><text><SENT sid="282" pm="."><plain>Morbidity outcomes were compared by using mixed effects logistic regression (SAS GLIMMIX procedure), including random effects of concession, and accounting for overdispersion. </plain></SENT>
<SENT sid="283" pm="."><plain>Treatment of diarrhea included treatments provided both by project field workers and health centers. </plain></SENT>
<SENT sid="284" pm="."><plain>For treatment of malaria, only the treatment provided by field workers was considered. </plain></SENT>
<SENT sid="285" pm="."><plain>Differences in mortality rates between enrollment and end of the study were compared with logistic regression including random effects of village and concession. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="sec010"><title><text><SENT sid="286" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="287" pm="."><plain>Of 3402 children screened for eligibility, 3220 were enrolled in the study (Fig. 1). </plain></SENT>
<SENT sid="288" pm="."><plain>Of these, 2435 were randomly assigned to one of the 4 treatment groups in the IC and 785 to the NIC. </plain></SENT>
<SENT sid="289" pm="."><plain>Among the four intervention groups, 19.5% dropped out by the final visit at 18 months. </plain></SENT>
<SENT sid="290" pm="."><plain>In the NIC, 15.2% were lost to anthropometric follow up at 18 months. </plain></SENT>
<SENT sid="291" pm="."><plain>Caregivers of 97.1% of children in the intervention groups provided morbidity surveillance information for at least 30 days and 78% provided information for at least 35 weeks, with no difference in participation rates among the four intervention groups. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0122242.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.g001</object-id><label>Fig 1</label><caption><title><text><SENT sid="292" pm="."><plain>Flow diagram of clusters and participant progression through the iLiNS-ZINC trial. </plain></SENT>
</text></title></caption><graphic xlink:href="pone.0122242.g001"/></fig></SecTag><p><text><SENT sid="293" pm="."><plain>Potential biases associated with loss to follow up were assessed. </plain></SENT>
<SENT sid="294" pm="."><plain>There were no differences in child, maternal, or household characteristics or SES between children who completed the study and those who dropped out, except for maternal age. </plain></SENT>
<SENT sid="295" pm="."><plain>Mothers of children who completed the study were slightly older than those of non-completers (27.0 ± 6.7 vs. 26.2 ± 6.7; P = 0.004). </plain></SENT>
</text></p><p><text><SENT sid="296" pm="."><plain>At enrollment, children had a mean age of 9.4 ± 0.35 months, and almost all children (99.9%) were still breastfed. </plain></SENT>
<SENT sid="297" pm="."><plain>Most baseline child and maternal characteristics did not differ among the groups (Table 2). </plain></SENT>
<SENT sid="298" pm="."><plain>However, WAZ and WLZ of children in LNS-Zn10 were significantly lower than in children in the LNS-TabZn5 group at baseline. </plain></SENT>
<SENT sid="299" pm="."><plain>There was also a significant difference in maternal education and marital status/rank. </plain></SENT>
<SENT sid="300" pm="."><plain>More women in NIC had no education (67.6%) compared to women in the 4 intervention groups (56.2–60.8%). </plain></SENT>
<SENT sid="301" pm="."><plain>Although other SES characteristics were not significantly different between groups, there was a tendency towards lower SES in the NIC. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0122242.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="302" pm="."><plain>Child and maternal baseline characteristics by group. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0122242.t002g" xlink:href="pone.0122242.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>LNS-Zn0 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>LNS-Zn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>LNS-Zn10 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>LNS-TabZn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>NIC </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>P-value 1  </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>602 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>613 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>603 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>617 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>785 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="7" align="left" rowspan="1"><text><SENT sid="315" pm="."><plain>Child characteristics </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>Age (months)  2  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>9.4 ± 0.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>9.4 ± 0.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>9.4 ± 0.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>9.4 ± 0.36 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>9.4 ± 0.35 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>0.447 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>Male </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>305 (51) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>299 (49) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>320 (53) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>304 (49) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>392 (50) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>0.600 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>Hemoglobin (g/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>90 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>90 ± 16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>89 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>90 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>89 ± 16 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>0.747 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>Adjusted ZPP 3  (μmol/mol heme) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>168.1 (161.1, 175.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>175.0 (168.0, 182.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>172.2 (165.0, 179.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>179.1 (171.6, 186.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>168.8 (1622, 175.7) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>0.293 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>Positive RDT 4  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>369 (61) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>358 (58) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>368 (61) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>351 (57) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>532 (68) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>0.244 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>Still breastfed </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>600 (100) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>612 (99.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>603 (100) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>617 (100) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>784 (99.9) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>1.000 </plain></SENT>
</text></td></tr><tr><td colspan="7" align="left" rowspan="1"><text><SENT sid="358" pm="."><plain>Maternal characteristics </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>Maternal age (yrs) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>26.6 ± 6.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>27.2 ± 6.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>26.9 ± 6.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>26.9 ± 7.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>26.8 + 6.5 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>0.669 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>Maternal height (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>162.3 ± 5.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>162.3 ± 5.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>161.7 ± 5.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>162.0 ± 5.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>162.5 ± 5.8 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>0.195 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>Maternal weight (kg) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>55.1 ± 7.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>55.3 ± 7.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>54.8 + 7.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>55.3 ± 8.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>54.5 ± 7.5 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>0.797 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>Maternal BMI (kg/m2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>20.9 ± 2.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>21.0 ± 2.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>20.9 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>21.0 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>20.6 ± 2.4 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>0.925 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>&lt; 18.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>80 (13.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>76 (12.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>90 (15.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>83 (13.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>125 (15.9) </plain></SENT>
</text></td><td rowspan="3" align="char" char="." colspan="1"><text><SENT sid="393" pm="."><plain>0.209 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>18.5–25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>487 (80.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>505 (82.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>471 (78.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>488 (79.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>624 (79.5) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>&gt; 25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>35 (5.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>31 (5.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>40 (6.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>46 (7.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>36 (4.6) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Maternal education </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>No education </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>359 (60.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>342 (56.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>337 (56.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>353 (57.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>528 (67.6) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>Informal education </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>179 (30.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>205 (33.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>194 (32.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>182 (29.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>167 (21.4) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>≥1 year of formal education </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>52 (8.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>61 (10.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>67 (11.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>77 (12.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>86 (11.0) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>Marital status/rank </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>0.005 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>Single, divorced, widowed </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>11 (1.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>19 (3.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>13 (2.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>15 (2.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>18 (2.3) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>Sole wife </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>333 (56.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>294 (48.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>333 (55.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>363 (59.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>390 (49.9) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>1st wife in polygamous household </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>91 (15.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>96 (15.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>99 (16.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>83 (13.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>149 (19.1) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>≥2nd wife in polygamous household </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>155 (26.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>197 (32.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>151 (25.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>151 (24.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>224 (28.7) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>Adjusted HFIAS 5  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>2.96 (2.62, 3.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>2.61 (2.32, 2.91) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>2.98 (2.64, 3.33) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>2.62 (2.33, 2.92) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>3.11 (2.81, 3.42) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>0.354 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>Asset index </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>0.10 (0.01, 0.18) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>0.15 (0.06, 0.24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>0.04 (-0.04, 0.12) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>0.16 (0.07, 0.24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>-0.34 (-0.42, -0.27) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>0.288 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><text><SENT sid="466" pm="."><plain>HFIAS, Household food insecurity access scale; LAZ, length-for-age z-score; positive RDT, positive result of a HRP-II (histidine-rich protein II) rapid diagnostic test for malaria parasites; WAZ, weight-for-age z-score; WLZ, weight-for-length z-score; ZPP, zinc protoporphyrin </plain></SENT>
</text></p></fn><fn id="t002fn002"><p><text><SENT sid="467" pm="."><plain>1P-values are for Chi square tests from survey procedure for comparing proportions in more than 2 categorical variables across groups or logistic regression for categorical variables, and linear mixed model for continuous variables. </plain></SENT>
<SENT sid="468" pm="."><plain>All comparison were done adjusting for cluster randomization (village, concession); </plain></SENT>
</text></p></fn><fn id="t002fn003"><p><text><SENT sid="469" pm="."><plain>2Mean ± SD, geometric mean (95% CI) and n (%), all such values. </plain></SENT>
</text></p></fn><fn id="t002fn004"><p><text><SENT sid="470" pm="."><plain>3ZPP adjusted categorically for RDT result; </plain></SENT>
</text></p></fn><fn id="t002fn005"><p><text><SENT sid="471" pm="."><plain>4Malaria is defined as a positive result of a HRP-II rapid diagnostic test for malaria parasites </plain></SENT>
</text></p></fn><fn id="t002fn006"><p><text><SENT sid="472" pm="."><plain>5Household food insecurity access scale (HFIAS) adjusted for season. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="473" pm="."><plain>Caregivers reported high daily adherence to SQ-LNS (96.8% ± 6.5%) and to tablets (97.4% ± 6.4%). </plain></SENT>
<SENT sid="474" pm="."><plain>Disappearance rates of both products also indicated high weekly adherence [29]. </plain></SENT>
<SENT sid="475" pm="."><plain>In contrast, during the 12-hr home observations only 62.6% and 54.1% of children at 11 and 16-months, respectively, were observed receiving SQ-LNS during the 12-hr observation periods and 32.0% and 27.1%, respectively, were observed receiving tablets. </plain></SENT>
</text></p><p><text><SENT sid="476" pm="."><plain>Mean baseline Hb was 89 ± 15 g/L, and 91.1% of the children were anemic at enrollment. </plain></SENT>
<SENT sid="477" pm="."><plain>At 18 months of age, mean Hb concentration increased significantly in IC compared to NIC, with no difference among the four intervention groups (Table 3). </plain></SENT>
<SENT sid="478" pm="."><plain>This increase in Hb concentration resulted in a final anemia prevalence of 79.1% in IC, compared with 91.1% of children in NIC (P&lt;0.0001). </plain></SENT>
<SENT sid="479" pm="."><plain>Mean baseline pZn was 69.0 ± 1.2 μg/dL and 35.2% of children had low pZn concentration at enrollment. </plain></SENT>
<SENT sid="480" pm="."><plain>There was no difference in final mean pZn among any of the study groups nor between IC and NIC. </plain></SENT>
<SENT sid="481" pm="."><plain>The intervention also did not have a significant impact on mean AGP and CRP concentrations at 18 months, nor on the prevalence of elevated AGP. </plain></SENT>
<SENT sid="482" pm="."><plain>However, significantly fewer IC children had elevated CRP at 18 months than NIC children (28.9% vs. 41.9%; P = 0.010). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0122242.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="483" pm="."><plain>Hemoglobin, plasma zinc concentration and indicators of inflammation in children at 9 and 18 months 1 . </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0122242.t003g" xlink:href="pone.0122242.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>LNS-Zn0 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>LNS-Zn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>LNS-Zn10 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>LNS-TabZn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>P-value among 4 intervention groups </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>IC </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>NIC </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>P-value between cohorts </plain></SENT>
</text></th></tr></thead><tbody><tr><td colspan="9" align="left" rowspan="1"><text><SENT sid="492" pm="."><plain>Hemoglobin  2  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>N at 9 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>602 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>613 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>603 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>617 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>2435 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>785 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>Hb at 9 mo (g/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>89 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>90 ± 16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>89 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>90 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>0.735 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>89 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>88 ± 16 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>0.417 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>N at 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>489 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>498 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>489 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>481 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>1960 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>664 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>Hb at 18 mo (g/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>97 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>97 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>98 ± 15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>98 ± 15 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>0.613 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>97 ± 15a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>88 ± 16b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>Anemic (Hb &lt;110 g/L) at 18 mo (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>392 (80.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>390 (78.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>384 (78.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>383 (79.6) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>0.848 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>1549 (79.1)b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>605 (91.1)a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td colspan="9" align="left" rowspan="1"><text><SENT sid="534" pm="."><plain>Adjusted plasma zinc concentration  3  ,  4  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>N at 9 and 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>84 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>73 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>310 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>93 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>pZn at 9 mo (μg/dL) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>68.1 ± 1.21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>68.1 ± 1.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>71.0 ± 1.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>71.3 ± 1.21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>0.212 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>69.6 ± 1.19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>67.0 ± 1.22 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>0.090 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>pZn at 18 mo (μg/dL) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>63.5 ± 1.21 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>64.6 ± 1.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>64.9 ± 1.19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>64.8 ± 1.15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>0.742 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>64.4 ± 1.18 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>64.7 ± 1.18 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>0.831 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>Low zinc status (pZn &lt; 65 μg/dL) at 18 mo (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>50 (59.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>42 (56.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>43 (54.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>34 (46.6) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>0.723 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>169 (54.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>51 (54.8) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>0.425 </plain></SENT>
</text></td></tr><tr><td colspan="9" align="left" rowspan="1"><text><SENT sid="569" pm="."><plain>C-reactive protein  3  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>N at 9 and 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>84 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>73 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>311 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>93 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>CRP at 9 mo (mg/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>1.94 ± 6.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>3.42 ± 5.35 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>2.59 ± 5.86 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>2.97 ± 6.34 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>0.225 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>2.65 ± 6.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>2.40 ± 5.87 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>0.605 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>CRP at 18 mo (mg/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>2.64 ± 5.31 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>2.85 ± 4.83 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>2.20 ± 4.73 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>2.12 ± 4.65 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>0.580 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>2.44 ± 4.88 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>3.12 ± 5.50 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>0.175 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>Elevated CRP (CRP ≥5 mg/L) at 18 mo (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>23 (27.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>27 (36.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>23 (29.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>17 (23.3) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>0.442 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>90 (28.9)b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>39 (41.9)a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>0.010 </plain></SENT>
</text></td></tr><tr><td colspan="9" align="left" rowspan="1"><text><SENT sid="604" pm="."><plain>α-1-acid glycoprotein  3  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>N at 9 and 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>84 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>75 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>79 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>73 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>311 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>93 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>AGP at 9 mo (g/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>1.08 ± 1.27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>1.09 ± 1.27 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>1.08 ± 1.25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>1.05 ± 1.33 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>0.863 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>1.08 ± 1.28 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>1.05 ± 1.28 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>0.325 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>AGP at 18 mo (g/L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>1.08 ± 1.39 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>1.07 ± 1.45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>1.07 ± 1.41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>1.03 ± 1.35 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>0.880 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>1.06 ± 1.40 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>1.11 ± 1.45 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>0.308 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>Elevated AGP (AGP ≥1.0 g/L) at 18 mo (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>49 (58.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>45 (60.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>48 (60.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>41 (56.2) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>0.967 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>183 (58.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>55 (59.1) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>0.829 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><text><SENT sid="639" pm="."><plain>AGP, α-1-acid glycoprotein; CRP, C-reactive protein; Hb, hemoglobin; IC, intervention cohort; mo, months; NIC, non-intervention cohort; pZn, plasma zinc concentration </plain></SENT>
</text></p></fn><fn id="t003fn002"><p><text><SENT sid="640" pm="."><plain>1 Adjusted mean ± SD, and n (%); all such values. </plain></SENT>
<SENT sid="641" pm="."><plain>Values in the same row with different superscript letters are significantly different (P&lt;0.05). </plain></SENT>
</text></p></fn><fn id="t003fn003"><p><text><SENT sid="642" pm="."><plain>2 Mean adjusted for cluster randomization (village, concession) and baseline value. </plain></SENT>
</text></p></fn><fn id="t003fn004"><p><text><SENT sid="643" pm="."><plain>3 Venous blood samples collected in a randomly selected sub-group only. </plain></SENT>
<SENT sid="644" pm="."><plain>Mean adjusted for cluster randomization (village) and baseline value. </plain></SENT>
</text></p></fn><fn id="t003fn005"><p><text><SENT sid="645" pm="."><plain>4 pZn also adjusted for time of blood draw, time since last breastfeeding episode and categorically adjusted for CRP and AGP concentration </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="646" pm="."><plain>At 18 months, adjusted mean length, weight, MUAC and HC were all significantly greater in IC children compared to NIC children (Table 4), but there were no differences among the 4 intervention groups in any of these outcomes. </plain></SENT>
<SENT sid="647" pm="."><plain>There was a significant modifying effect of initial length on the difference in growth between IC and NIC children (P = 0.023; Fig. 2). </plain></SENT>
<SENT sid="648" pm="."><plain>In particular, the change in length was significantly greater among IC children with the lowest 10th percentile of initial length compared to NIC children (P&lt;0.0001). </plain></SENT>
<SENT sid="649" pm="."><plain>At baseline, mean LAZ, WAZ and WLZ were -1.21 ± 1.10, -1.42 ± 1.14, and -0.99 ± 1.05, respectively, in all five groups combined. </plain></SENT>
<SENT sid="650" pm="."><plain>These z-scores were significantly greater in IC children compared to NIC at 18 months, with no difference among the 4 intervention groups. </plain></SENT>
<SENT sid="651" pm="."><plain>The increase in length and weight in IC from 9 to 18 months resulted in a significantly lower prevalence of stunting, underweight and wasting in IC compared to NIC. </plain></SENT>
<SENT sid="652" pm="."><plain>At 18 months, 39.3% of NIC children were stunted compared to 29.3% of IC children (P&lt;0.0001) and 13.5% of NIC children were wasted compared to 8.7% of IC children (P = 0.0003). </plain></SENT>
<SENT sid="653" pm="."><plain>The prevalence of stunting did not differ among the four intervention groups. </plain></SENT>
<SENT sid="654" pm="."><plain>However, the prevalence of underweight was marginally higher in children in the LNS-Zn10 group compared to children in the LNS-TabZn5 group (26.3% vs 15.2%, P = 0.089). </plain></SENT>
<SENT sid="655" pm="."><plain>Similarly, the prevalence of wasting in LNS-Zn10 (13.2%) was significantly higher than in LNS-TabZn5 (5.4%) and LNS-Zn0 (7.2%; P = 0.003). </plain></SENT>
<SENT sid="656" pm="."><plain>In the 5-group comparison of wasting prevalence, there was no difference between LNS-Zn10, LNS-Zn5 and NIC (P&gt;0.05). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0122242.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.g002</object-id><label>Fig 2</label><caption><title><text><SENT sid="657" pm="."><plain>Change in length by initial length in young children in Burkina Faso. </plain></SENT>
</text></title></caption><graphic xlink:href="pone.0122242.g002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone.0122242.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="658" pm="."><plain>Anthropometry at baseline and after 9 mo of intervention in young Burkinabe children. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0122242.t004g" xlink:href="pone.0122242.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>LNS-Zn0 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>LNS-Zn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>LNS-Zn10 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>LNS-TabZn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>P-value among 4 groups 2  </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>IC </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>NIC </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>P-value between cohorts 2  </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>602 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>613 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>603 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>617 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>2435 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>785 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>Length at 9 mo (cm) 1  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>68.7 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>68.7 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>68.5 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>68.9 ± 2.7 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>0.138 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>68.7 ± 2.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>68.9 ±2.7 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>0.393 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>Length at 18 mo (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>77.7 ± 3.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>77.7 ± 3.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>77.7 ± 3.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>77.8 ± 2.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>0.962 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="689" pm="."><plain>77.7 ± 3.0a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>77.0 ± 3.4b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>Weight at 9 mo (kg) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>7.41 ± 0.95ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>7.41 ± 1.03ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>7.30 ± 0.95b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>7.49 ± 1.03a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>0.013 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>7.40 ± 0.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="699" pm="."><plain>7.44 ± 1.04 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="700" pm="."><plain>0.625 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="701" pm="."><plain>Weight at 18 mo (kg) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="702" pm="."><plain>9.31 ± 1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="703" pm="."><plain>9.30 ± 1.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="704" pm="."><plain>9.29 ± 1.11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="705" pm="."><plain>9.33 ± 1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="706" pm="."><plain>0. </plain></SENT>
<SENT sid="707" pm="."><plain>784 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="708" pm="."><plain>9.31 ± 1.07 a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="709" pm="."><plain>9.02 ± 1.18b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="710" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="711" pm="."><plain>MUAC at 9 mo (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="712" pm="."><plain>13.3 ± 1.1ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="713" pm="."><plain>13.3 ± 1.2ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="714" pm="."><plain>13.2 ±1.1b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="715" pm="."><plain>13.4 ± 1.2a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="716" pm="."><plain>0.002 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="717" pm="."><plain>13.3 ± 1.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="718" pm="."><plain>13.3 ± 1.2 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="719" pm="."><plain>0.684 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="720" pm="."><plain>MUAC at 18 mo (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="721" pm="."><plain>13.8 ± 1.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>13.8 ± 1.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>13.8 ± 1.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>13.8 ± 0.99 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>0.553 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>13.8 ± 1.0a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>13.5 ± 1.1b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>HC at 9 mo (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>42.6 ± 1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="731" pm="."><plain>42.6 ± 1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>42.6 ± 1.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>42.7 ± 1.3 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>0.789 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>42.6 ± 1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>42.6 ± 1.3 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>0.330 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>HC at 18 mo (cm) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>44.6 ± 1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>44.6 ± 1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>44.6 ± 1.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>44.6 ± 1.3 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>0.983 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>44.6 ± 1.3a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>44.4 ± 1.3b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="746" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>LAZ at 9 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>-1.22 ± 1.07ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>-1.21 ± 1.11ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>-1.33 ± 1.07b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>-1.14 ± 1.10a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>0.029 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>-1.23 ± 1.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>-1.19 ± 1.13 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>0.631 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>LAZ at 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>-1.44 ± 1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>-1.45 ± 1.09 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>-1.45 ± 1.10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>-1.43 ± 1.00 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="761" pm="."><plain>0.968 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>-1.44 ± 1.06a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>-1.74 ± 1.17b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>WAZ at 9 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>-1.42 ± 1.10ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>-1.41 ± 1.16ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>-1.58 ± 1.08b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="769" pm="."><plain>-1.34 ± 1.16a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>0.003 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="771" pm="."><plain>-1.44 ± 1.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>-1.42 ± 1.19 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>0.834 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>WAZ at 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>-1.22 ± 0.94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>-1.24 ± 1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>-1.24 ± 1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>-1.20 ± 0.94 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>0.721 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>-1.23 ± 0.98a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>-1.51 ± 1.12b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>WLZ at 9 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="784" pm="."><plain>-0.99 ± 1.06ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>-0.98 ± 1.08ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>-1.11 ± 0.99b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>-0.91 ± 1.06a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>0.015 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>-1.00 ± 1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>-1.01 ± 1.06 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>0.801 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>WLZ at 18 mo </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>-0.72 ± 0.89 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>-0.74 ± 0.94 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>-0.77 ± 1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>-0.70 ± 0.89 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>0.472 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>-0.73 ± 0.93a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="799" pm="."><plain>-0.93 ± 1.01b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>&lt; 0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>Stunting at 9 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>139 (23.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>135 (22.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>158 (26.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="805" pm="."><plain>124 (20.2) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="806" pm="."><plain>0.138 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="807" pm="."><plain>556 (22.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="808" pm="."><plain>164 (20.9) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="809" pm="."><plain>0.318 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="810" pm="."><plain>Stunting at 18 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="811" pm="."><plain>146 (29.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="812" pm="."><plain>149 (30.1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="813" pm="."><plain>161 (32.8) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="814" pm="."><plain>117 (24.4) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="815" pm="."><plain>0.536 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="816" pm="."><plain>573 (29.3) b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="817" pm="."><plain>261 (39.3)a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="818" pm="."><plain>&lt;0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="819" pm="."><plain>Underweight at 9 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="820" pm="."><plain>159 (26.5)b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="821" pm="."><plain>180 (29.4)ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="822" pm="."><plain>205 (34.0)a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="823" pm="."><plain>163 (26.4)ab </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="824" pm="."><plain>0.015 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="825" pm="."><plain>707 (29.0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="826" pm="."><plain>244 (31.1) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="827" pm="."><plain>0.560 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="828" pm="."><plain>Underweight at 18 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="829" pm="."><plain>91 (18.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="830" pm="."><plain>102 (20.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="831" pm="."><plain>129 (26.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="832" pm="."><plain>73 (15.2) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="833" pm="."><plain>0.051 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="834" pm="."><plain>395 (20.1)b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="835" pm="."><plain>206 (30.9)a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="836" pm="."><plain>0.0001 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="837" pm="."><plain>Wasting at 9 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="838" pm="."><plain>100 (16.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="839" pm="."><plain>94 (15.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="840" pm="."><plain>111 (18.4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="841" pm="."><plain>88 (14.3) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="842" pm="."><plain>0.261 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="843" pm="."><plain>393 (16.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="844" pm="."><plain>136 (17.3) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="845" pm="."><plain>0.674 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="846" pm="."><plain>Wasting at 18 mo, n (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="847" pm="."><plain>35 (7.2)b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="848" pm="."><plain>44 (8.9)ab </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="849" pm="."><plain>65 (13.2)a </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="850" pm="."><plain>26 (5.4)b </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="851" pm="."><plain>0.003 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="852" pm="."><plain>170 (8.7) b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="853" pm="."><plain>90 (13.5)a </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="854" pm="."><plain>0.0003 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p><text><SENT sid="855" pm="."><plain>HC, head circumference; LAZ, length-for-age z-score; mo, months; MUAC, mid-upper arm circumference; WAZ, weight-for-age z-score; WLZ, weight-for-length z-score </plain></SENT>
</text></p></fn><fn id="t004fn002"><p><text><SENT sid="856" pm="."><plain>1 Adjusted mean ± SD and n (%), all such values. </plain></SENT>
<SENT sid="857" pm="."><plain>Values in the same row with different superscript letters are significantly different (P&lt;0.05). </plain></SENT>
</text></p></fn><fn id="t004fn003"><p><text><SENT sid="858" pm="."><plain>2 Adjusting for cluster randomization (village, concession), baseline value, age and potential co-variates, when applicable. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="859" pm="."><plain>During the 9 months intervention period in the IC, the mean (95% confidence interval (CI)) prevalence of diarrhea in all four groups combined was 3.08% (2.94, 3.22) and the mean (± SD) diarrhea incidence was 1.10 ± 1.03 per 100 child-days. </plain></SENT>
<SENT sid="860" pm="."><plain>These did not differ among the four intervention groups (Table 5). </plain></SENT>
<SENT sid="861" pm="."><plain>The intra-cluster (i.e., concession) correlation for diarrhea incidence was ~0.16, resulting in a design effect of about 1.10 for diarrhea incidence. </plain></SENT>
<SENT sid="862" pm="."><plain>The proportion of all diarrhea episodes treated according to the study protocol ranged from 36.4% to 41.3% and did not differ by study group. </plain></SENT>
<SENT sid="863" pm="."><plain>At enrollment, the proportion of children with a positive RDT (61.4% overall) did not differ among groups. </plain></SENT>
<SENT sid="864" pm="."><plain>During the 9 months follow up, the overall mean malaria prevalence and mean malaria incidence did not differ by group. </plain></SENT>
<SENT sid="865" pm="."><plain>Almost all malaria episodes were treated (99.0%), and treatment rates did not differ by study group. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0122242.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0122242.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="866" pm="."><plain>Prevalence and incidence of diarrhea and malaria among young Burkinabe children receiving SQ-LNS and tablets from 9 to 18 months of age. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0122242.t005g" xlink:href="pone.0122242.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="867" pm="."><plain>LNS-Zn0 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="868" pm="."><plain>LNS-Zn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="869" pm="."><plain>LNS-Zn10 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="870" pm="."><plain>LNS-TabZn5 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="871" pm="."><plain>P-value 6  </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="872" pm="."><plain>N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="873" pm="."><plain>579 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="874" pm="."><plain>593 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="875" pm="."><plain>593 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="876" pm="."><plain>599 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="6" align="left" rowspan="1"><text><SENT sid="877" pm="."><plain>Prevalence (%)  1  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="878" pm="."><plain>Diarrhea 2  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="879" pm="."><plain>3.20 (2.93, 3.47) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="880" pm="."><plain>3.14 (2.84, 3.44) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="881" pm="."><plain>2.97 (2.70, 3.24) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="882" pm="."><plain>3.01 (2.73, 3.29) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="883" pm="."><plain>0.403 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="884" pm="."><plain>Malaria 3  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="885" pm="."><plain>1.56 (1.44, 1.69) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="886" pm="."><plain>1.67 (1.51, 1.83) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="887" pm="."><plain>1.59 (1.45, 1.73) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="888" pm="."><plain>1.61 (1.47, 1.76) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="889" pm="."><plain>0.754 </plain></SENT>
</text></td></tr><tr><td colspan="6" align="left" rowspan="1"><text><SENT sid="890" pm="."><plain>Incidence (per 100 child-days)  1  </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="891" pm="."><plain>Diarrhea </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="892" pm="."><plain>1.11 ± 1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="893" pm="."><plain>1.14 ± 1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="894" pm="."><plain>1.06 ± 0.98 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="895" pm="."><plain>1.08 ± 1.02 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="896" pm="."><plain>0.589 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="897" pm="."><plain>Treated diarrhea </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="898" pm="."><plain>0.41 ± 0.48 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="899" pm="."><plain>0.41 ± 0.54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="900" pm="."><plain>0.41 ± 0.51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="901" pm="."><plain>0.38 ± 0.52 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="902" pm="."><plain>0.711 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="903" pm="."><plain>% of diarrhea episodes treated 4  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="904" pm="."><plain>39.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="905" pm="."><plain>36.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="906" pm="."><plain>41.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="907" pm="."><plain>37.6 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="908" pm="."><plain>0.330 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="909" pm="."><plain>Malaria </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="910" pm="."><plain>0.55 ± 0.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="911" pm="."><plain>0.55 ± 0.52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="912" pm="."><plain>0.54 ± 0.48 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="913" pm="."><plain>0.52 ± 0.49 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="914" pm="."><plain>0.877 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="915" pm="."><plain>Treated malaria </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="916" pm="."><plain>0.55 ± 0.49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="917" pm="."><plain>0.54 ± 0.52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="918" pm="."><plain>0.53 ± 0.48 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="919" pm="."><plain>0.52 ± 0.48 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="920" pm="."><plain>0.813 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="921" pm="."><plain>% of malaria episodes treated 5  </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="922" pm="."><plain>99.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="923" pm="."><plain>99.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="924" pm="."><plain>99.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="925" pm="."><plain>98.3 </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="926" pm="."><plain>0.518 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p><text><SENT sid="927" pm="."><plain>1Prevalence shown as mean percent (95% CI) and incidence as mean ± SD per 100 child-days. </plain></SENT>
<SENT sid="928" pm="."><plain>Means are weighted for number of days of observation for prevalence and number of days at risk for incidence. </plain></SENT>
</text></p></fn><fn id="t005fn002"><p><text><SENT sid="929" pm="."><plain>2Diarrhea defined as ≥3 liquid or semi-liquid stools reported by caregiver </plain></SENT>
</text></p></fn><fn id="t005fn003"><p><text><SENT sid="930" pm="."><plain>3Malaria was defined by a positive result of a HRP-II (histidine-rich protein II) rapid diagnostic test for malaria parasites </plain></SENT>
</text></p></fn><fn id="t005fn004"><p><text><SENT sid="931" pm="."><plain>4Treatment of diarrhea included treatments provided by project field workers and health centers </plain></SENT>
</text></p></fn><fn id="t005fn005"><p><text><SENT sid="932" pm="."><plain>5 Treatment of malaria was considered if provided by project field workers </plain></SENT>
</text></p></fn><fn id="t005fn006"><p><text><SENT sid="933" pm="."><plain>6 P-values obtained from binominal regression models, which included a random effect of concession, baseline characteristics and potential covariates and accounted for overdispersion. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="934" pm="."><plain>There were no significant differences in hospitalization (P = 0.394) or mortality (P = 0.125) rates among children in the four intervention groups. </plain></SENT>
<SENT sid="935" pm="."><plain>At 18 months, caregivers were asked whether they sought medical services for the study children, and retrospective reports were marginally higher in IC versus NIC (57% vs 54%, P = 0.083), but did not differ among all five study groups (P = 0.412). </plain></SENT>
<SENT sid="936" pm="."><plain>The mortality rate was significantly lower in IC than NIC (1.4% vs 3.2% P = 0.005). </plain></SENT>
<SENT sid="937" pm="."><plain>When all five study groups were compared, this difference was only significant between NIC and LNS-Zn5 (Fig. 1). </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="conclusions" id="sec011"><title><text><SENT sid="938" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="939" pm="."><plain>Provision of SQ-LNS along with simple feeding advice and treatment of confirmed cases of malaria and reported diarrhea resulted in significantly greater growth velocity and lower prevalence of stunting, wasting and anemia among children in the IC compared to children in the NIC. </plain></SENT>
<SENT sid="940" pm="."><plain>The growth effect was significantly greater among children whose initial length was below the 10th percentile of initial length of study participants, indicating that those with the greatest degree of initial growth restriction benefitted most. </plain></SENT>
<SENT sid="941" pm="."><plain>This reduction in stunting prevalence is of public health significance considering that stunting is associated with increased risk of morbidity and mortality, impaired cognition and educational performance, lower adult wages, and, when accompanied by excessive weight gain later in childhood, increased risk of nutrition-related chronic diseases [1,2]. </plain></SENT>
</text></p><p><text><SENT sid="942" pm="."><plain>Within the IC, there were no detectable differences in zinc-related outcomes, such as increased growth, morbidity reduction or change in pZn, regardless of the amount or form of supplemental zinc, implying that the different amounts of zinc provided in SQ-LNS or as dispersible tablet were neither protective nor harmful. </plain></SENT>
<SENT sid="943" pm="."><plain>Possible explanations for these findings are poor adherence to supplements, poor absorption of zinc from these supplements, deficiencies of other nutrients causing limited responses, or lack of zinc deficiency in the study population. </plain></SENT>
<SENT sid="944" pm="."><plain>Although reported adherence was very high, 12-hr home observations during home visits revealed that only 59% of children were offered SQ-LNS, and only 30% of the children received a tablet during the 12-hr home observation. </plain></SENT>
<SENT sid="945" pm="."><plain>Moreover, almost half of all children (46%) who were offered a tablet on the day of observation received the tablet less than 30 min after a meal [29]. </plain></SENT>
<SENT sid="946" pm="."><plain>Thus, it is possible that adherence to the zinc tablets and/or absorption of zinc from the tablets were less than optimal. </plain></SENT>
<SENT sid="947" pm="."><plain>It is less likely that concurrent deficiencies of other nutrients limited responses since SQ-LNS provided all IC children with 21 micronutrients and essential fatty acids [11]. </plain></SENT>
<SENT sid="948" pm="."><plain>Absence of zinc deficiency in the study population is also an unlikely explanation since 54% of children had low pZn at the end of the study. </plain></SENT>
</text></p><p><text><SENT sid="949" pm="."><plain>Although there were no significant differences in mean WLZ among the four intervention groups at the end of the study, the wasting prevalence at 18 months was significantly higher in LNS-Zn10 (13.2%) compared to LNS-Zn0 (7.2%) and LNS-TabZn5 (5.4%; P = 0.003). </plain></SENT>
<SENT sid="950" pm="."><plain>It is unlikely that this higher wasting prevalence in the LNS-Zn10 group was due to an adverse effect of zinc. </plain></SENT>
<SENT sid="951" pm="."><plain>A meta-analysis of 22 studies of preventive zinc supplementation provided either as tablets or syrup, including 13 studies that provided 10 mg supplemental zinc, found a small, marginally significant, positive effect of zinc on change in weight-for-height z-score [6]. </plain></SENT>
<SENT sid="952" pm="."><plain>A previous study found no differences in LNS acceptability or LNS consumption in relation to zinc content [26], so differences in LNS consumption is also an unlikely explanation. </plain></SENT>
<SENT sid="953" pm="."><plain>Rather, it seems that the difference in final wasting prevalence is a chance finding given that we found no other significant differences in any of the growth and morbidity outcomes among the intervention groups. </plain></SENT>
</text></p><p><text><SENT sid="954" pm="."><plain>While larger quantity LNS has proven useful in the treatment of children with severe acute malnutrition [38], the potential of SQ-LNS to prevent malnutrition and improve health and nutrition status is only beginning to be explored. </plain></SENT>
<SENT sid="955" pm="."><plain>In the present study, the standardized mean difference of LAZ at the end of the study was 0.27 between the children in IC who received the intervention package compared to children in NIC. </plain></SENT>
<SENT sid="956" pm="."><plain>Similarly, Adu-Afarwuah and colleagues found a standardized mean difference of final LAZ of 0.26 between Ghanaian children who received SQ-LNS compared to children in a non-intervention group, although the difference in final LAZ at 12 months of age was not significant, probably due to the smaller sample size in the Ghana study [14]. </plain></SENT>
<SENT sid="957" pm="."><plain>Over the 9-months intervention period we found an effect size in length of 0.48. </plain></SENT>
<SENT sid="958" pm="."><plain>In contrast, a smaller but also significant effect size of 0.11 was found for the longitudinal average monthly growth effect in Haiti [15]. </plain></SENT>
<SENT sid="959" pm="."><plain>Possible explanations for these differences are the community-based provision of disease treatment and/or differences in initial LAZ of these study populations. </plain></SENT>
<SENT sid="960" pm="."><plain>Whereas treatment of diarrhea and malaria was provided by the field team in the present study, no treatment was provided in the studies in Ghana and Haiti. </plain></SENT>
<SENT sid="961" pm="."><plain>In addition, the mean baseline LAZ was much lower in the Burkinabe children (-1.21 ± 1.10) compared to the baseline LAZ of -0.20 ± 1.0 and -0.39 ± 1.20 in the studies in Ghana and Haiti, respectively. </plain></SENT>
<SENT sid="962" pm="."><plain>A fourth trial in young Malawian children with mean initial LAZ of -1.00 ± 0.77 found that infants with baseline LAZ below the median who received 50 g LNS gained more length than children who received a micronutrient-fortified maize-soy flour for 12 months [13]. </plain></SENT>
<SENT sid="963" pm="."><plain>This is consistent with our findings that children with the greatest degree of growth restriction benefitted most. </plain></SENT>
</text></p><p><text><SENT sid="964" pm="."><plain>Diarrhea is associated with a small decrease in linear growth over the long term [39], but findings from longitudinal studies investigating the impact of malaria on growth are inconsistent [40–43]. </plain></SENT>
<SENT sid="965" pm="."><plain>One study found that only Plasmodium vivax was a predictor of stunting and wasting and not Plasmodium falciparum [44]; the latter was the most common parasite type in our study. </plain></SENT>
<SENT sid="966" pm="."><plain>Because all children in the intervention groups received SQ-LNS along with simple feeding advice and illness treatment, it is uncertain what proportion of the growth impact in IC children can be attributed to SQ-LNS alone and how much was due to the malaria and/or diarrhea treatment. </plain></SENT>
<SENT sid="967" pm="."><plain>In the present study, the frequency of treated malaria episodes did not have an impact on average change in growth [45], and it is unlikely that the provision of ORS would have an impact on growth. </plain></SENT>
<SENT sid="968" pm="."><plain>Nevertheless, to explore the possible effects of illness treatment we compared the results of the present study with the outcomes of another zinc trial in a neighboring health district. </plain></SENT>
<SENT sid="969" pm="."><plain>In the neighboring study, zinc supplementation was provided only as dispersible zinc tablets along with community-based treatment of malaria and diarrhea, following the same treatment protocol. </plain></SENT>
<SENT sid="970" pm="."><plain>In that study, where no SQ-LNS was provided, zinc supplements and illness treatment did not increase the growth of young children compared to a non-intervention group [46], suggesting that SQ-LNS may have been the critical growth-promoting component of the current intervention package. </plain></SENT>
<SENT sid="971" pm="."><plain>However, other differences in the study designs prevent firm conclusions. </plain></SENT>
</text></p><p><text><SENT sid="972" pm="."><plain>We found a significant reduction in anemia prevalence in the IC children. </plain></SENT>
<SENT sid="973" pm="."><plain>These findings are consistent with the study of SQ-LNS in Ghana, which also found a significant reduction in anemia prevalence in children receiving SQ-LNS from 6 to 12 months of age compared to a non-intervention group [19]. </plain></SENT>
<SENT sid="974" pm="."><plain>Similarly, studies of MNP also consistently find a beneficial impact on anemia prevalence [47]. </plain></SENT>
<SENT sid="975" pm="."><plain>However, 79% of all children in IC still had a Hb concentration &lt;110 g/L at the end of the intervention, despite the daily provision of 6 mg iron, 400 μg retinol and B-vitamins in SQ-LNS, along with treatment for malaria and diarrhea. </plain></SENT>
<SENT sid="976" pm="."><plain>Thus, additional interventions would be needed to reduce the high anemia burden in this population. </plain></SENT>
</text></p><p><text><SENT sid="977" pm="."><plain>Strengths of the current study include the large sample size, high participation rates, and regular training and rigorous supervision of field staff. </plain></SENT>
<SENT sid="978" pm="."><plain>All anthropometrists participated in regular standardization sessions as recommended by WHO [48]. </plain></SENT>
<SENT sid="979" pm="."><plain>In addition, the present study included multiple strategies to assess adherence to the study products [29] and blood collection and plasma analyses followed procedures recommended by IZiNCG [31]. </plain></SENT>
</text></p><p><text><SENT sid="980" pm="."><plain>Several limitations in the present study also have to be considered. </plain></SENT>
<SENT sid="981" pm="."><plain>One limitation was the cluster assignment to intervention and non-intervention communities. </plain></SENT>
<SENT sid="982" pm="."><plain>To compensate for the cluster design, we enrolled a large number of communities (25 IC and 9 NIC villages) and included a design effect of 1.5 in calculating the NIC sample size. </plain></SENT>
<SENT sid="983" pm="."><plain>Also, adherence to the different study products could not be definitely ascertained despite the use of a variety of strategies to assess adherence [29]. </plain></SENT>
<SENT sid="984" pm="."><plain>Another weakness of our study is related to the partially blind study design. </plain></SENT>
<SENT sid="985" pm="."><plain>While participants, field workers and investigators remained blinded to the intervention groups in IC during data collection, data analyses and result interpretation, the comparisons between IC and NIC could not be blinded. </plain></SENT>
<SENT sid="986" pm="."><plain>However, all final anthropometric indicators were consistently greater in IC and the stunting prevalence of 22.4% at 9 months in all children and 39.3% at 18 months of age in NIC are comparable to the national stunting prevalence in the same age range (25.1% in 9–11 months old children and 41.6% in children aged 18–23 months) in 2010 [49]. </plain></SENT>
<SENT sid="987" pm="."><plain>Moreover, a similar study in a neighboring health district with weekly contact for morbidity surveillance and product distribution did not find a difference in growth between the intervention and non-intervention group [46]. </plain></SENT>
<SENT sid="988" pm="."><plain>Thus, it is unlikely that the Hawthorne effect could explain the observed growth impact. </plain></SENT>
<SENT sid="989" pm="."><plain>Despite these considerations, the inclusion of the NIC in our trial strengthened the study design, as it allowed the comparison of the intervention package to the current standard care in rural southwestern Burkina Faso. </plain></SENT>
</text></p><p><text><SENT sid="990" pm="."><plain>Because the trial was implemented in a malaria-endemic area, SQ-LNS and feeding recommendations for the iLiNS studies were designed to minimize possible risks of iron supplementation [11]. </plain></SENT>
<SENT sid="991" pm="."><plain>In particular, the daily iron dose was half the recommended dose for MNP [50], and caregivers were advised to feed the daily ration in two separate servings to avoid consuming a large bolus of iron at a single meal. </plain></SENT>
<SENT sid="992" pm="."><plain>Moreover, treatment was provided for diagnosed cases of malaria and diarrhea. </plain></SENT>
<SENT sid="993" pm="."><plain>A recent trial of MNP conducted in Pakistan found an increase in reported diarrhea and chest in-drawing among 6 to 18 month old children who received MNP compared to a non-supplemented control group, although there was no difference in the rates of persistent diarrhea, fever, or hospitalizations [51]. </plain></SENT>
<SENT sid="994" pm="."><plain>Because we did not collect continuous morbidity data in the NIC, so as not to interfere with current treatment practices, the present trial does not allow such a direct comparison of morbidity rates between IC and NIC. </plain></SENT>
<SENT sid="995" pm="."><plain>In an effort to assess potential risks of the intervention, we asked caregivers at the end of the study to report retrospectively any medical care seeking at local health centers and regional hospitals over the 9-months study period. </plain></SENT>
<SENT sid="996" pm="."><plain>These reports were marginally higher in the IC (57%) compared to the NIC (54%; P = 0.083), which was likely due to the fact that children in IC were referred to the health center by the morbidity surveillance worker for any illness other than uncomplicated diarrhea and malaria. </plain></SENT>
<SENT sid="997" pm="."><plain>At the same time, there was a significantly lower mortality rate in IC than NIC (1.4% vs 3.2%; P = 0.005). </plain></SENT>
<SENT sid="998" pm="."><plain>While our study was not powered to assess hospitalization and mortality rates, these findings together imply that providing SQ-LNS as prescribed in the current study, along with malaria and diarrhea treatment, was likely not harmful. </plain></SENT>
</text></p><p><text><SENT sid="999" pm="."><plain>In summary, there were no differences in growth and morbidity outcomes among the four intervention groups. </plain></SENT>
<SENT sid="1000" pm="."><plain>Thus, the optimal level of zinc to be added to SQ-LNS remains uncertain. </plain></SENT>
<SENT sid="1001" pm="."><plain>Nevertheless, the provision of SQ-LNS along with brief feeding advice and illness treatment of diagnosed cases of malaria and diarrhea had a significant beneficial impact on stunting, wasting and anemia reduction. </plain></SENT>
<SENT sid="1002" pm="."><plain>While we are not able to distinguish the impact of SQ-LNS from the impact of health services, provision of malaria and diarrhea treatment is unlikely the sole reason for the beneficial impact on growth. </plain></SENT>
<SENT sid="1003" pm="."><plain>The findings of the present study suggest that provision of SQ-LNS is a promising strategy to reduce childhood stunting and wasting when coupled with greater access to health care, especially among children at greatest risk of stunting. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="sec012"><title><text><SENT sid="1004" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0122242.s001"><label>S1 CONSORT Checklist</label><caption><title><text><SENT sid="1005" pm="."><plain>CONSORT Checklist. </plain></SENT>
</text></title><p><text><SENT sid="1006" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0122242.s001.pdf"><caption><p><text><SENT sid="1007" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0122242.s002"><label>S1 Protocol</label><caption><title><text><SENT sid="1008" pm="."><plain>Trial Protocol. </plain></SENT>
</text></title><p><text><SENT sid="1009" pm="."><plain>(PDF) </plain></SENT>
</text></p></caption><media xlink:href="pone.0122242.s002.pdf"><caption><p><text><SENT sid="1010" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="1011" pm="."><plain>We thank the entire study staff. </plain></SENT>
<SENT sid="1012" pm="."><plain>Special thanks go to Lucien Bado and Faustin Ye (Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso) for planning and coordinating blood sample collection, Antonio Perfecto (Children’s Hospital of Oakland Research Institute, USA) for pZn analyses, Janet Peerson (University of California Davis, USA) for assistance with the programming and statistical analyses and the iLiNS Project Steering Committee (<ext-link ext-link-type="uri" xlink:href="http://www.ilins.org">www.ilins.org</ext-link>) and Mary Arimond (University of California Davis, USA) for technical support. </plain></SENT>
<SENT sid="1013" pm="."><plain>Finally, we sincerely appreciate the support of the participating children and their parents, the local communities and the staff of the Health District of Dandé. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0122242.ref001"><text><SENT sid="1014" pm="."><plain>1 BlackRE, VictoraCG, WalkerSP, BhuttaZA, ChristianP, de OnisM, et al Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382: 427–451. 10.1016/S0140-6736(13)60937-X <?supplied-pmid 23746772?>23746772 </plain></SENT>
</text></ref><ref id="pone.0122242.ref002"><text><SENT sid="1015" pm="."><plain>2 de OnisM, DeweyKG, BorghiE, OnyangoAW, BlossnerM, DaelmansB, et al The World Health Organization's global target for reducing childhood stunting by 2025: rationale and proposed actions. Matern Child Nutr. 2013;9 Suppl 2: 6–26. 10.1111/mcn.12075 <?supplied-pmid 24074315?>24074315 </plain></SENT>
</text></ref><ref id="pone.0122242.ref003"><text><SENT sid="1016" pm="."><plain>3 WalkerCL, RudanI, LiuL, NairH, TheodoratouE, BhuttaZA, et al Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381: 1405–1416. 10.1016/S0140-6736(13)60222-6 <?supplied-pmid 23582727?>23582727 </plain></SENT>
</text></ref><ref id="pone.0122242.ref004"><text><SENT sid="1017" pm="."><plain>4 BhuttaZA, DasJK, WalkerN, RizviA, CampbellH, RudanI, et al Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381: 1417–1429. 10.1016/S0140-6736(13)60648-0 <?supplied-pmid 23582723?>23582723 </plain></SENT>
</text></ref><ref id="pone.0122242.ref005"><text><SENT sid="1018" pm="."><plain>5 MurrayCJ, OrtbladKF, GuinovartC, LimSS, WolockTM, RobertsDA, et al Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384: 1005–1070. 10.1016/S0140-6736(14)60844-8 <?supplied-pmid 25059949?>25059949 </plain></SENT>
</text></ref><ref id="pone.0122242.ref006"><text><SENT sid="1019" pm="."><plain>6 BrownKH, PeersonJM, BakerSK, HessSY. Preventive zinc supplementation among infants, preschoolers, and older prepubertal children. Food Nutr Bull. 2009;30: S12–40. <?supplied-pmid 19472600?>19472600 </plain></SENT>
</text></ref><ref id="pone.0122242.ref007"><text><SENT sid="1020" pm="."><plain>7 RothDE, RichardSA, BlackRE. Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials. Int J Epidemiol. 2010;39: 795–808. 10.1093/ije/dyp391 <?supplied-pmid 20156999?>20156999 </plain></SENT>
</text></ref><ref id="pone.0122242.ref008"><text><SENT sid="1021" pm="."><plain>8 ImdadA, BhuttaZA. Effect of preventive zinc supplementation on linear growth in children under 5 years of age in developing countries: a meta-analysis of studies for input to the lives saved tool. BMC Public Health. 2011;11 Suppl 3: S22 10.1186/1471-2458-11-S3-S22 <?supplied-pmid 21501440?>21501440 </plain></SENT>
</text></ref><ref id="pone.0122242.ref009"><text><SENT sid="1022" pm="."><plain>9 YakoobMY, TheodoratouE, JabeenA, ImdadA, EiseleTP, FergusonJ, et al Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health. 2011;11 Suppl 3: S23 10.1186/1471-2458-11-S3-S23 <?supplied-pmid 21501441?>21501441 </plain></SENT>
</text></ref><ref id="pone.0122242.ref010"><text><SENT sid="1023" pm="."><plain>10 Mayo-WilsonE, JuniorJA, ImdadA, DeanS, ChanXH, ChanES, et al Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev. 2014;5: CD009384. </plain></SENT>
</text></ref><ref id="pone.0122242.ref011"><text><SENT sid="1024" pm="."><plain>11Arimond M, Zeilani M, Jungjohann S, Brown KH, Ashorn P, Allen LH, et al. Considerations in developing lipid-based nutrient supplements for prevention of undernutrition: experience from the International Lipid-Based Nutrient Supplements (iLiNS) Project. </plain></SENT>
<SENT sid="1026" pm="."><plain>Matern Child Nutr. </plain></SENT>
<SENT sid="1027" pm="."><plain>2013: [epub ahead of print]; 10.1111/mcn.12049. </plain></SENT>
</text></ref><ref id="pone.0122242.ref012"><text><SENT sid="1028" pm="."><plain>12 KuusipaloH, MaletaK, BriendA, ManaryM, AshornP. Growth and change in blood haemoglobin concentration among underweight Malawian infants receiving fortified spreads for 12 weeks: a preliminary trial. J Pediatr Gastroenterol Nutr. 2006;43: 525–532. <?supplied-pmid 17033530?>17033530 </plain></SENT>
</text></ref><ref id="pone.0122242.ref013"><text><SENT sid="1029" pm="."><plain>13 PhukaJC, MaletaK, ThakwalakwaC, CheungYB, BriendA, ManaryMJ, et al Complementary feeding with fortified spread and incidence of severe stunting in 6- to 18-month-old rural Malawians. Arch Pediatr Adolesc Med. 2008;162: 619–626. 10.1001/archpedi.162.7.619 <?supplied-pmid 18606932?>18606932 </plain></SENT>
</text></ref><ref id="pone.0122242.ref014"><text><SENT sid="1030" pm="."><plain>14 Adu-AfarwuahS, LarteyA, BrownKH, ZlotkinS, BriendA, DeweyKG. Randomized comparison of 3 types of micronutrient supplements for home fortification of complementary foods in Ghana: effects on growth and motor development. Am J Clin Nutr. 2007;86: 412–420. <?supplied-pmid 17684213?>17684213 </plain></SENT>
</text></ref><ref id="pone.0122242.ref015"><text><SENT sid="1031" pm="."><plain>15 IannottiLL, DulienceSJ, GreenJ, JosephS, FrancoisJ, AntenorML, et al Linear growth increased in young children in an urban slum of Haiti: a randomized controlled trial of a lipid-based nutrient supplement. Am J Clin Nutr. 2013;99: 198–208. 10.3945/ajcn.113.063883 <?supplied-pmid 24225356?>24225356 </plain></SENT>
</text></ref><ref id="pone.0122242.ref016"><text><SENT sid="1032" pm="."><plain>16Mangani C, Maleta K, Phuka J, Cheung YB, Thakwalakwa C, Dewey K, et al. Effect of complementary feeding with lipid-based nutrient supplements and corn-soy blend on the incidence of stunting and linear growth among 6- to 18-month-old infants and children in rural Malawi. </plain></SENT>
<SENT sid="1034" pm="."><plain>Matern Child Nutr. </plain></SENT>
<SENT sid="1035" pm="."><plain>2013: [e-pub ahead of print]; 10.1111/mcn.12068. </plain></SENT>
</text></ref><ref id="pone.0122242.ref017"><text><SENT sid="1036" pm="."><plain>17 BisimwaG, OwinoVO, BahwereP, DramaixM, DonnenP, DibariF, et al Randomized controlled trial of the effectiveness of a soybean-maize-sorghum-based ready-to-use complementary food paste on infant growth in South Kivu, Democratic Republic of Congo. Am J Clin Nutr. 2012;95: 1157–1164. 10.3945/ajcn.111.028704 <?supplied-pmid 22492382?>22492382 </plain></SENT>
</text></ref><ref id="pone.0122242.ref018"><text><SENT sid="1037" pm="."><plain>18 HessSY, PeersonJM, KingJC, BrownKH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull. 2007;28: S403–429. <?supplied-pmid 17988005?>17988005 </plain></SENT>
</text></ref><ref id="pone.0122242.ref019"><text><SENT sid="1038" pm="."><plain>19 Adu-AfarwuahS, LarteyA, BrownKH, ZlotkinS, BriendA, DeweyKG. Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana. Am J Clin Nutr. 2008;87: 929–938. <?supplied-pmid 18400716?>18400716 </plain></SENT>
</text></ref><ref id="pone.0122242.ref020"><text><SENT sid="1039" pm="."><plain>20 ZlotkinS, ArthurP, SchauerC, AntwiKY, YeungG, PiekarzA. Home-fortification with iron and zinc sprinkles or iron sprinkles alone successfully treats anemia in infants and young children. J Nutr. 2003;133: 1075–1080. <?supplied-pmid 12672922?>12672922 </plain></SENT>
</text></ref><ref id="pone.0122242.ref021"><text><SENT sid="1040" pm="."><plain>21 TroeschB, van StuijvenbergME, SmutsCM, KrugerHS, BiebingerR, HurrellRF, et al A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight-for-age Z-scores in South African children. J Nutr. 2011;141: 237–242. 10.3945/jn.110.129247 <?supplied-pmid 21178093?>21178093 </plain></SENT>
</text></ref><ref id="pone.0122242.ref022"><text><SENT sid="1041" pm="."><plain>22 SamadpourK, LongKZ, HayatbakhshR, MarksGC. Randomised comparison of the effects of Sprinkles and Foodlets with the currently recommended supplement (Drops) on micronutrient status and growth in Iranian children. Eur J Clin Nutr. 2011;65: 1287–1294. 10.1038/ejcn.2011.124 <?supplied-pmid 21750564?>21750564 </plain></SENT>
</text></ref><ref id="pone.0122242.ref023"><text><SENT sid="1042" pm="."><plain>23 JackSJ, OuK, CheaM, ChhinL, DevenishR, DunbarM, et al Effect of micronutrient sprinkles on reducing anemia: a cluster-randomized effectiveness trial. Arch Pediatr Adolesc Med. 2012;166: 842–850. 10.1001/archpediatrics.2012.1003 <?supplied-pmid 22801933?>22801933 </plain></SENT>
</text></ref><ref id="pone.0122242.ref024"><text><SENT sid="1043" pm="."><plain>24World Health Organization Physical status: The use and interpretation of anthropometry. </plain></SENT>
<SENT sid="1044" pm="."><plain>Technical Report Series No. 854. </plain></SENT>
<SENT sid="1045" pm="."><plain>Geneva: World Health Organization. </plain></SENT>
<SENT sid="1046" pm="."><plain>1995. </plain></SENT>
</text></ref><ref id="pone.0122242.ref025"><text><SENT sid="1047" pm="."><plain>25 BrownKH, PeersonJM, RiveraJ, AllenLH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2002;75: 1062–1071. <?supplied-pmid 12036814?>12036814 </plain></SENT>
</text></ref><ref id="pone.0122242.ref026"><text><SENT sid="1048" pm="."><plain>26 HessSY, BadoL, AaronGJ, OuedraogoJB, ZeilaniM, BrownKH. Acceptability of zinc-fortified, lipid-based nutrient supplements (LNS) prepared for young children in Burkina Faso. Matern Child Nutr. 2010;7: 357–367. 10.1111/j.1740-8709.2010.00287.x <?supplied-pmid 21159124?>21159124 </plain></SENT>
</text></ref><ref id="pone.0122242.ref027"><text><SENT sid="1049" pm="."><plain>27 World Health Organization, Food and Agriculture Organization Vitamin and mineral requirements in human nutrition Report of a joint FAO/WHO expert consultation. Geneva, Switzerland: World Health Organization 2004. </plain></SENT>
</text></ref><ref id="pone.0122242.ref028"><text><SENT sid="1050" pm="."><plain>28 Food and Agriculture Organization Fats and fatty acids in human nutrition: Report of an expert consultation Rome, Italy: Food and Agriculture Organization 2010. </plain></SENT>
</text></ref><ref id="pone.0122242.ref029"><text><SENT sid="1051" pm="."><plain>29Abbeddou S, Hess SY, Yakes Jimenez E, Some JW, Vosti SA, Guissou RM, et al. Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabe children participating in a community-based intervention trial. </plain></SENT>
<SENT sid="1053" pm="."><plain>Matern Child Nutr. </plain></SENT>
<SENT sid="1054" pm="."><plain>2014: Dec 17, 10.1111/mcn.12162. </plain></SENT>
</text></ref><ref id="pone.0122242.ref030"><text><SENT sid="1055" pm="."><plain>30 UlijaszekSJ, KerrDA. Anthropometric measurement error and the assessment of nutritional status. Br J Nutr. 1999;82: 165–177. <?supplied-pmid 10655963?>10655963 </plain></SENT>
</text></ref><ref id="pone.0122242.ref031"><text><SENT sid="1056" pm="."><plain>31 BrownKH, RiveraJA, BhuttaZ, GibsonRS, KingJC, LönnerdalB, et al International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. </plain></SENT>
<SENT sid="1057" pm="."><plain>Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull. 2004;25: S99–203. <?supplied-pmid 18046856?>18046856 </plain></SENT>
</text></ref><ref id="pone.0122242.ref032"><text><SENT sid="1058" pm="."><plain>32 WessellsKR, OuedraogoZP, RouambaN, HessSY, OuedraogoJB, BrownKH. Short-term zinc supplementation with dispersible tablets or zinc sulfate solution yields similar positive effects on plasma zinc concentration of young children in Burkina Faso: A randomized controlled trial. J Pediatr. 2011;160: 129–135. 10.1016/j.jpeds.2011.06.051 <?supplied-pmid 21871635?>21871635 </plain></SENT>
</text></ref><ref id="pone.0122242.ref033"><text><SENT sid="1059" pm="."><plain>33 KillileaDW, AmesBN. Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc Natl Acad Sci U S A. 2008;105: 5768–5773. 10.1073/pnas.0712401105 <?supplied-pmid 18391207?>18391207 </plain></SENT>
</text></ref><ref id="pone.0122242.ref034"><text><SENT sid="1060" pm="."><plain>34 ErhardtJG, EstesJE, PfeifferCM, BiesalskiHK, CraftNE. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr. 2004;134: 3127–3132. <?supplied-pmid 15514286?>15514286 </plain></SENT>
</text></ref><ref id="pone.0122242.ref035"><text><SENT sid="1061" pm="."><plain>35 World Health Organization WHO growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development Geneva: World Health Organization. 2006. </plain></SENT>
</text></ref><ref id="pone.0122242.ref036"><text><SENT sid="1062" pm="."><plain>36 CoatesJ, SwindaleA, BilinskyP. Household Food Insecurity Access Scale (HFIAS) for measurement of food access: Indicator guide Washington, DC: USAID 2007. </plain></SENT>
</text></ref><ref id="pone.0122242.ref037"><text><SENT sid="1063" pm="."><plain>37 VyasS, KumaranayakeL. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21: 459–468. <?supplied-pmid 17030551?>17030551 </plain></SENT>
</text></ref><ref id="pone.0122242.ref038"><text><SENT sid="1064" pm="."><plain>38 LentersLM, WaznyK, WebbP, AhmedT, BhuttaZA. Treatment of severe and moderate acute malnutrition in low- and middle-income settings: a systematic review, meta-analysis and Delphi process. BMC Public Health. 2013;13 Suppl 3: S23 10.1186/1471-2458-13-S3-S23 <?supplied-pmid 24564235?>24564235 </plain></SENT>
</text></ref><ref id="pone.0122242.ref039"><text><SENT sid="1065" pm="."><plain>39 RichardSA, BlackRE, GilmanRH, GuerrantRL, KangG, LanataCF, et al Diarrhea in early childhood: short-term association with weight and long-term association with length. Am J Epidemiol. 2013;178: 1129–1138. 10.1093/aje/kwt094 <?supplied-pmid 23966558?>23966558 </plain></SENT>
</text></ref><ref id="pone.0122242.ref040"><text><SENT sid="1066" pm="."><plain>40 NyakerigaAM, Troye-BlombergM, ChemtaiAK, MarshK, WilliamsTN. Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr. 2004;80: 1604–1610. <?supplied-pmid 15585775?>15585775 </plain></SENT>
</text></ref><ref id="pone.0122242.ref041"><text><SENT sid="1067" pm="."><plain>41 PadonouG, Le PortA, CottrellG, GuerraJ, ChoudatI, RachasA, et al Prematurity, intrauterine growth retardation and low birth weight: risk factors in a malaria-endemic area in southern Benin. Trans R Soc Trop Med Hyg. 2014;108: 77–83. 10.1093/trstmh/trt099 <?supplied-pmid 24336697?>24336697 </plain></SENT>
</text></ref><ref id="pone.0122242.ref042"><text><SENT sid="1068" pm="."><plain>42 KangH, KreuelsB, AdjeiO, KrumkampR, MayJ, SmallDS. The causal effect of malaria on stunting: a Mendelian randomization and matching approach. Int J Epidemiol. 2013;42: 1390–1398. 10.1093/ije/dyt116 <?supplied-pmid 23925429?>23925429 </plain></SENT>
</text></ref><ref id="pone.0122242.ref043"><text><SENT sid="1069" pm="."><plain>43 LeeG, YoriP, OlorteguiMP, PanW, CaulfieldL, GilmanRH, et al Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol. 2012;41: 531–539. 10.1093/ije/dyr190 <?supplied-pmid 22258823?>22258823 </plain></SENT>
</text></ref><ref id="pone.0122242.ref044"><text><SENT sid="1070" pm="."><plain>44 WilliamsTN, MaitlandK, PhelpsL, BennettS, PetoTE, VijiJ, et al Plasmodium vivax: a cause of malnutrition in young children. QJM. 1997;90: 751–757. <?supplied-pmid 9536339?>9536339 </plain></SENT>
</text></ref><ref id="pone.0122242.ref045"><text><SENT sid="1071" pm="."><plain>45Somé JW, Abbeddou S, Yakes Jimenez E, Hess SY, Ouédraogo ZP, Guissou RM, et al. Treated malaria does not affect physical growth and hemoglobin concentration of young children in Burkina Faso Faseb J. 2015, in press. </plain></SENT>
</text></ref><ref id="pone.0122242.ref046"><text><SENT sid="1074" pm="."><plain>46 BecqueyE, OuédraogoC, HessSY, RouambaN, PrinceL, VostiSA, et al Comparison of preventive and therapeutic zinc supplementation programs for young children in Burkina Faso: a randomized, masked, community-based trial. Faseb J. 2013;27: 845819. 10.1096/fj.13-0301ufm <?supplied-pmid 23450005?>23450005 </plain></SENT>
</text></ref><ref id="pone.0122242.ref047"><text><SENT sid="1075" pm="."><plain>47 SalamRA, MacphailC, DasJK, BhuttaZA. Effectiveness of Micronutrient Powders (MNP) in women and children. BMC Public Health. 2013;13 Suppl 3: S22 10.1186/1471-2458-13-S3-S22 <?supplied-pmid 24564207?>24564207 </plain></SENT>
</text></ref><ref id="pone.0122242.ref048"><text><SENT sid="1076" pm="."><plain>48 World Health Organization Measuring change in nutritional status: Guidelines for assessing the nutritional impact of supplementary feeding programmes for vulnerable groups Geneva, Switzerland: World Health Organization 1983. </plain></SENT>
</text></ref><ref id="pone.0122242.ref049"><text><SENT sid="1077" pm="."><plain>49Macro International Inc. </plain></SENT>
<SENT sid="1078" pm="."><plain>MEASURE DHS STATcompiler. </plain></SENT>
<SENT sid="1079" pm="."><plain>Available: <ext-link ext-link-type="uri" xlink:href="http://www.measuredhs.com">http://www.measuredhs.com</ext-link>, Accessed 2014 January 20. </plain></SENT>
</text></ref><ref id="pone.0122242.ref050"><text><SENT sid="1080" pm="."><plain>50 World Health Organization Use of multiple micronutrient powders for home fortification of foods consumed by infants and children 6–23 months of age Geneva, Switzerland: World Health Organization. 2011. </plain></SENT>
</text></ref><ref id="pone.0122242.ref051"><text><SENT sid="1081" pm="."><plain>51 SoofiS, CousensS, IqbalSP, AkhundT, KhanJ, AhmedI, et al Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet. 2013;382: 29–40. 10.1016/S0140-6736(13)60437-7 <?supplied-pmid 23602230?>23602230 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
